nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Skin disorder—Flutamide—prostate cancer	0.00566	0.00567	CcSEcCtD
Emedastine—Cardiac disorder—Bicalutamide—prostate cancer	0.00551	0.00553	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Degarelix—prostate cancer	0.00541	0.00543	CcSEcCtD
Emedastine—Nervous system disorder—Estradiol valerate/Dienogest—prostate cancer	0.00539	0.0054	CcSEcCtD
Emedastine—Discomfort—Degarelix—prostate cancer	0.00538	0.0054	CcSEcCtD
Emedastine—Pain—Estrone—prostate cancer	0.00538	0.0054	CcSEcCtD
Emedastine—Sinusitis—Ethinyl Estradiol—prostate cancer	0.00525	0.00526	CcSEcCtD
Emedastine—Mental disorder—Bicalutamide—prostate cancer	0.00521	0.00522	CcSEcCtD
Emedastine—Nervous system disorder—Degarelix—prostate cancer	0.00512	0.00514	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Cabazitaxel—prostate cancer	0.0051	0.00511	CcSEcCtD
Emedastine—Skin disorder—Degarelix—prostate cancer	0.00507	0.00509	CcSEcCtD
Emedastine—Discomfort—Cabazitaxel—prostate cancer	0.00507	0.00509	CcSEcCtD
Emedastine—Rhinitis—Ethinyl Estradiol—prostate cancer	0.00504	0.00505	CcSEcCtD
Emedastine—Pain—Nilutamide—prostate cancer	0.005	0.00502	CcSEcCtD
Emedastine—Eye irritation—Docetaxel—prostate cancer	0.00492	0.00494	CcSEcCtD
Emedastine—Nervous system disorder—Cabazitaxel—prostate cancer	0.00483	0.00484	CcSEcCtD
Emedastine—Lacrimation—Epirubicin—prostate cancer	0.00482	0.00484	CcSEcCtD
Emedastine—Tachycardia—Cabazitaxel—prostate cancer	0.0048	0.00482	CcSEcCtD
Emedastine—Skin disorder—Cabazitaxel—prostate cancer	0.00478	0.00479	CcSEcCtD
Emedastine—Eye irritation—Capecitabine—prostate cancer	0.00477	0.00478	CcSEcCtD
Emedastine—Pain—Estradiol valerate/Dienogest—prostate cancer	0.0047	0.00471	CcSEcCtD
Emedastine—Eye disorder—Ethinyl Estradiol—prostate cancer	0.00469	0.00471	CcSEcCtD
Emedastine—Pruritus—Estramustine—prostate cancer	0.00466	0.00468	CcSEcCtD
Emedastine—Asthenia—Abiraterone—prostate cancer	0.00459	0.00461	CcSEcCtD
Emedastine—Lacrimation increased—Docetaxel—prostate cancer	0.00456	0.00457	CcSEcCtD
Emedastine—Pain—Degarelix—prostate cancer	0.00447	0.00448	CcSEcCtD
Emedastine—Lacrimation—Doxorubicin—prostate cancer	0.00446	0.00447	CcSEcCtD
Emedastine—Pruritus—Estrone—prostate cancer	0.00445	0.00447	CcSEcCtD
Emedastine—Lacrimation increased—Capecitabine—prostate cancer	0.00442	0.00443	CcSEcCtD
Emedastine—Mental disorder—Ethinyl Estradiol—prostate cancer	0.0044	0.00441	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.00437	0.00439	CcSEcCtD
Emedastine—Keratitis—Epirubicin—prostate cancer	0.00437	0.00438	CcSEcCtD
Emedastine—Sinusitis—Goserelin—prostate cancer	0.00432	0.00433	CcSEcCtD
Emedastine—Sinusitis—Conjugated Estrogens—prostate cancer	0.00428	0.00429	CcSEcCtD
Emedastine—Pain—Cabazitaxel—prostate cancer	0.00421	0.00422	CcSEcCtD
Emedastine—Asthenia—Nilutamide—prostate cancer	0.0042	0.00421	CcSEcCtD
Emedastine—Asthenia—Flutamide—prostate cancer	0.00418	0.00419	CcSEcCtD
Emedastine—Rash—Estramustine—prostate cancer	0.00416	0.00417	CcSEcCtD
Emedastine—Dermatitis—Estramustine—prostate cancer	0.00415	0.00416	CcSEcCtD
Emedastine—Rhinitis—Goserelin—prostate cancer	0.00414	0.00416	CcSEcCtD
Emedastine—Nervous system disorder—Bicalutamide—prostate cancer	0.00414	0.00415	CcSEcCtD
Emedastine—Pruritus—Nilutamide—prostate cancer	0.00414	0.00415	CcSEcCtD
Emedastine—Headache—Estramustine—prostate cancer	0.00413	0.00414	CcSEcCtD
Emedastine—Pruritus—Flutamide—prostate cancer	0.00412	0.00413	CcSEcCtD
Emedastine—Rhinitis—Conjugated Estrogens—prostate cancer	0.0041	0.00412	CcSEcCtD
Emedastine—Skin disorder—Bicalutamide—prostate cancer	0.0041	0.00411	CcSEcCtD
Emedastine—Keratitis—Doxorubicin—prostate cancer	0.00404	0.00406	CcSEcCtD
Emedastine—Rash—Abiraterone—prostate cancer	0.00404	0.00405	CcSEcCtD
Emedastine—Dermatitis—Abiraterone—prostate cancer	0.00403	0.00404	CcSEcCtD
Emedastine—Rash—Estrone—prostate cancer	0.00397	0.00398	CcSEcCtD
Emedastine—Dermatitis—Estrone—prostate cancer	0.00397	0.00398	CcSEcCtD
Emedastine—Headache—Estrone—prostate cancer	0.00394	0.00396	CcSEcCtD
Emedastine—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00394	0.00395	CcSEcCtD
Emedastine—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00389	0.0039	CcSEcCtD
Emedastine—Eye disorder—Goserelin—prostate cancer	0.00386	0.00387	CcSEcCtD
Emedastine—Cardiac disorder—Goserelin—prostate cancer	0.00384	0.00385	CcSEcCtD
Emedastine—Eye disorder—Conjugated Estrogens—prostate cancer	0.00383	0.00384	CcSEcCtD
Emedastine—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.0038	0.00381	CcSEcCtD
Emedastine—Dry eye—Capecitabine—prostate cancer	0.00376	0.00377	CcSEcCtD
Emedastine—Asthenia—Degarelix—prostate cancer	0.00375	0.00376	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.0037	0.00371	CcSEcCtD
Emedastine—Pruritus—Degarelix—prostate cancer	0.0037	0.00371	CcSEcCtD
Emedastine—Rash—Nilutamide—prostate cancer	0.00369	0.0037	CcSEcCtD
Emedastine—Dermatitis—Nilutamide—prostate cancer	0.00368	0.00369	CcSEcCtD
Emedastine—Discomfort—Ethinyl Estradiol—prostate cancer	0.00368	0.00369	CcSEcCtD
Emedastine—Rash—Flutamide—prostate cancer	0.00367	0.00368	CcSEcCtD
Emedastine—Dermatitis—Flutamide—prostate cancer	0.00367	0.00368	CcSEcCtD
Emedastine—Headache—Nilutamide—prostate cancer	0.00366	0.00367	CcSEcCtD
Emedastine—Headache—Flutamide—prostate cancer	0.00365	0.00366	CcSEcCtD
Emedastine—Mental disorder—Goserelin—prostate cancer	0.00362	0.00363	CcSEcCtD
Emedastine—Pain—Bicalutamide—prostate cancer	0.00361	0.00362	CcSEcCtD
Emedastine—Mental disorder—Conjugated Estrogens—prostate cancer	0.00359	0.0036	CcSEcCtD
Emedastine—Asthenia—Cabazitaxel—prostate cancer	0.00353	0.00354	CcSEcCtD
Emedastine—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.0035	0.00351	CcSEcCtD
Emedastine—Stinging—Epirubicin—prostate cancer	0.0035	0.00351	CcSEcCtD
Emedastine—Dysgeusia—Conjugated Estrogens—prostate cancer	0.00349	0.0035	CcSEcCtD
Emedastine—Skin disorder—Ethinyl Estradiol—prostate cancer	0.00347	0.00348	CcSEcCtD
Emedastine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00346	0.00347	CcSEcCtD
Emedastine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00346	0.00347	CcSEcCtD
Emedastine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00344	0.00345	CcSEcCtD
Emedastine—Sinusitis—Estradiol—prostate cancer	0.00342	0.00343	CcSEcCtD
Emedastine—Vision blurred—Goserelin—prostate cancer	0.00339	0.0034	CcSEcCtD
Emedastine—Vision blurred—Conjugated Estrogens—prostate cancer	0.00336	0.00337	CcSEcCtD
Emedastine—Rash—Degarelix—prostate cancer	0.00329	0.0033	CcSEcCtD
Emedastine—Dermatitis—Degarelix—prostate cancer	0.00329	0.0033	CcSEcCtD
Emedastine—Rhinitis—Estradiol—prostate cancer	0.00329	0.00329	CcSEcCtD
Emedastine—Headache—Degarelix—prostate cancer	0.00327	0.00328	CcSEcCtD
Emedastine—Eye pain—Capecitabine—prostate cancer	0.00327	0.00328	CcSEcCtD
Emedastine—Stinging—Doxorubicin—prostate cancer	0.00324	0.00325	CcSEcCtD
Emedastine—Sinusitis—Mitoxantrone—prostate cancer	0.00319	0.0032	CcSEcCtD
Emedastine—Headache—Cabazitaxel—prostate cancer	0.00308	0.00309	CcSEcCtD
Emedastine—Lacrimation increased—Epirubicin—prostate cancer	0.00308	0.00309	CcSEcCtD
Emedastine—Eye disorder—Estradiol—prostate cancer	0.00306	0.00307	CcSEcCtD
Emedastine—Rhinitis—Mitoxantrone—prostate cancer	0.00306	0.00307	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.00304	0.00305	CcSEcCtD
Emedastine—Cardiac disorder—Estradiol—prostate cancer	0.00304	0.00305	CcSEcCtD
Emedastine—Asthenia—Bicalutamide—prostate cancer	0.00303	0.00304	CcSEcCtD
Emedastine—Discomfort—Goserelin—prostate cancer	0.00303	0.00304	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.00301	0.00302	CcSEcCtD
Emedastine—Pruritus—Bicalutamide—prostate cancer	0.00299	0.003	CcSEcCtD
Emedastine—Nervous system disorder—Goserelin—prostate cancer	0.00288	0.00289	CcSEcCtD
Emedastine—Mental disorder—Estradiol—prostate cancer	0.00287	0.00288	CcSEcCtD
Emedastine—Tachycardia—Goserelin—prostate cancer	0.00287	0.00287	CcSEcCtD
Emedastine—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.00285	0.00286	CcSEcCtD
Emedastine—Skin disorder—Goserelin—prostate cancer	0.00285	0.00286	CcSEcCtD
Emedastine—Lacrimation increased—Doxorubicin—prostate cancer	0.00285	0.00285	CcSEcCtD
Emedastine—Tachycardia—Conjugated Estrogens—prostate cancer	0.00284	0.00285	CcSEcCtD
Emedastine—Skin disorder—Conjugated Estrogens—prostate cancer	0.00283	0.00283	CcSEcCtD
Emedastine—Abnormal dreams—Epirubicin—prostate cancer	0.0028	0.00281	CcSEcCtD
Emedastine—Dysgeusia—Estradiol—prostate cancer	0.00279	0.0028	CcSEcCtD
Emedastine—Rash—Bicalutamide—prostate cancer	0.00266	0.00267	CcSEcCtD
Emedastine—Dermatitis—Bicalutamide—prostate cancer	0.00266	0.00267	CcSEcCtD
Emedastine—Headache—Bicalutamide—prostate cancer	0.00264	0.00265	CcSEcCtD
Emedastine—Dry eye—Epirubicin—prostate cancer	0.00262	0.00263	CcSEcCtD
Emedastine—Dysgeusia—Mitoxantrone—prostate cancer	0.0026	0.00261	CcSEcCtD
Emedastine—Abnormal dreams—Doxorubicin—prostate cancer	0.00259	0.0026	CcSEcCtD
Emedastine—Asthenia—Ethinyl Estradiol—prostate cancer	0.00256	0.00257	CcSEcCtD
Emedastine—Pruritus—Ethinyl Estradiol—prostate cancer	0.00252	0.00253	CcSEcCtD
Emedastine—Pain—Goserelin—prostate cancer	0.00251	0.00252	CcSEcCtD
Emedastine—Vision blurred—Mitoxantrone—prostate cancer	0.0025	0.00251	CcSEcCtD
Emedastine—Pain—Conjugated Estrogens—prostate cancer	0.00249	0.00249	CcSEcCtD
Emedastine—Dry eye—Doxorubicin—prostate cancer	0.00242	0.00243	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.00241	0.00242	CcSEcCtD
Emedastine—Discomfort—Estradiol—prostate cancer	0.0024	0.00241	CcSEcCtD
Emedastine—Eye disorder—Etoposide—prostate cancer	0.00237	0.00238	CcSEcCtD
Emedastine—Cardiac disorder—Etoposide—prostate cancer	0.00236	0.00236	CcSEcCtD
Emedastine—Nervous system disorder—Estradiol—prostate cancer	0.00228	0.00229	CcSEcCtD
Emedastine—Eye pain—Epirubicin—prostate cancer	0.00228	0.00229	CcSEcCtD
Emedastine—Tachycardia—Estradiol—prostate cancer	0.00227	0.00228	CcSEcCtD
Emedastine—Skin disorder—Estradiol—prostate cancer	0.00226	0.00227	CcSEcCtD
Emedastine—Rash—Ethinyl Estradiol—prostate cancer	0.00225	0.00226	CcSEcCtD
Emedastine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00225	0.00225	CcSEcCtD
Emedastine—Discomfort—Mitoxantrone—prostate cancer	0.00224	0.00224	CcSEcCtD
Emedastine—Headache—Ethinyl Estradiol—prostate cancer	0.00224	0.00224	CcSEcCtD
Emedastine—Dysgeusia—Etoposide—prostate cancer	0.00217	0.00217	CcSEcCtD
Emedastine—Tachycardia—Mitoxantrone—prostate cancer	0.00212	0.00212	CcSEcCtD
Emedastine—Rhinitis—Docetaxel—prostate cancer	0.00212	0.00212	CcSEcCtD
Emedastine—Eye pain—Doxorubicin—prostate cancer	0.00211	0.00212	CcSEcCtD
Emedastine—Asthenia—Goserelin—prostate cancer	0.00211	0.00211	CcSEcCtD
Emedastine—Skin disorder—Mitoxantrone—prostate cancer	0.00211	0.00211	CcSEcCtD
Emedastine—Asthenia—Conjugated Estrogens—prostate cancer	0.00209	0.00209	CcSEcCtD
Emedastine—Pruritus—Goserelin—prostate cancer	0.00208	0.00208	CcSEcCtD
Emedastine—Pruritus—Conjugated Estrogens—prostate cancer	0.00206	0.00206	CcSEcCtD
Emedastine—Rhinitis—Capecitabine—prostate cancer	0.00205	0.00205	CcSEcCtD
Emedastine—Pain—Estradiol—prostate cancer	0.00199	0.002	CcSEcCtD
Emedastine—Eye disorder—Docetaxel—prostate cancer	0.00197	0.00198	CcSEcCtD
Emedastine—Cardiac disorder—Docetaxel—prostate cancer	0.00196	0.00196	CcSEcCtD
Emedastine—Eye disorder—Capecitabine—prostate cancer	0.00191	0.00192	CcSEcCtD
Emedastine—Cardiac disorder—Capecitabine—prostate cancer	0.0019	0.0019	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00187	0.00187	CcSEcCtD
Emedastine—Discomfort—Etoposide—prostate cancer	0.00186	0.00187	CcSEcCtD
Emedastine—Pain—Mitoxantrone—prostate cancer	0.00186	0.00186	CcSEcCtD
Emedastine—Rash—Goserelin—prostate cancer	0.00185	0.00186	CcSEcCtD
Emedastine—Dermatitis—Goserelin—prostate cancer	0.00185	0.00186	CcSEcCtD
Emedastine—Mental disorder—Docetaxel—prostate cancer	0.00185	0.00185	CcSEcCtD
Emedastine—Headache—Goserelin—prostate cancer	0.00184	0.00185	CcSEcCtD
Emedastine—Rash—Conjugated Estrogens—prostate cancer	0.00183	0.00184	CcSEcCtD
Emedastine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00183	0.00184	CcSEcCtD
Emedastine—Headache—Conjugated Estrogens—prostate cancer	0.00182	0.00183	CcSEcCtD
Emedastine—Dysgeusia—Docetaxel—prostate cancer	0.0018	0.0018	CcSEcCtD
Emedastine—Mental disorder—Capecitabine—prostate cancer	0.00179	0.0018	CcSEcCtD
Emedastine—Olanzapine—CYP2C19—prostate cancer	0.00176	0.611	CrCbGaD
Emedastine—Tachycardia—Etoposide—prostate cancer	0.00176	0.00177	CcSEcCtD
Emedastine—Skin disorder—Etoposide—prostate cancer	0.00175	0.00176	CcSEcCtD
Emedastine—Dysgeusia—Capecitabine—prostate cancer	0.00174	0.00175	CcSEcCtD
Emedastine—Eye disorder—Prednisone—prostate cancer	0.0017	0.00171	CcSEcCtD
Emedastine—Vision blurred—Capecitabine—prostate cancer	0.00168	0.00168	CcSEcCtD
Emedastine—Asthenia—Estradiol—prostate cancer	0.00167	0.00168	CcSEcCtD
Emedastine—Pruritus—Estradiol—prostate cancer	0.00165	0.00165	CcSEcCtD
Emedastine—Mental disorder—Prednisone—prostate cancer	0.00159	0.0016	CcSEcCtD
Emedastine—Asthenia—Mitoxantrone—prostate cancer	0.00156	0.00156	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.00155	0.00156	CcSEcCtD
Emedastine—Pain—Etoposide—prostate cancer	0.00154	0.00155	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.0015	0.00151	CcSEcCtD
Emedastine—Discomfort—Capecitabine—prostate cancer	0.0015	0.0015	CcSEcCtD
Emedastine—Vision blurred—Prednisone—prostate cancer	0.00149	0.0015	CcSEcCtD
Emedastine—Sinusitis—Epirubicin—prostate cancer	0.00149	0.00149	CcSEcCtD
Emedastine—Nervous system disorder—Docetaxel—prostate cancer	0.00147	0.00147	CcSEcCtD
Emedastine—Rash—Estradiol—prostate cancer	0.00147	0.00147	CcSEcCtD
Emedastine—Dermatitis—Estradiol—prostate cancer	0.00147	0.00147	CcSEcCtD
Emedastine—Tachycardia—Docetaxel—prostate cancer	0.00146	0.00147	CcSEcCtD
Emedastine—Headache—Estradiol—prostate cancer	0.00146	0.00146	CcSEcCtD
Emedastine—Skin disorder—Docetaxel—prostate cancer	0.00146	0.00146	CcSEcCtD
Emedastine—Rhinitis—Epirubicin—prostate cancer	0.00143	0.00143	CcSEcCtD
Emedastine—Nervous system disorder—Capecitabine—prostate cancer	0.00142	0.00143	CcSEcCtD
Emedastine—Tachycardia—Capecitabine—prostate cancer	0.00142	0.00142	CcSEcCtD
Emedastine—Skin disorder—Capecitabine—prostate cancer	0.00141	0.00141	CcSEcCtD
Emedastine—Sinusitis—Doxorubicin—prostate cancer	0.00138	0.00138	CcSEcCtD
Emedastine—Rash—Mitoxantrone—prostate cancer	0.00137	0.00137	CcSEcCtD
Emedastine—Dermatitis—Mitoxantrone—prostate cancer	0.00137	0.00137	CcSEcCtD
Emedastine—Headache—Mitoxantrone—prostate cancer	0.00136	0.00136	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00134	0.00134	CcSEcCtD
Emedastine—Discomfort—Prednisone—prostate cancer	0.00133	0.00134	CcSEcCtD
Emedastine—Eye disorder—Epirubicin—prostate cancer	0.00133	0.00133	CcSEcCtD
Emedastine—Cardiac disorder—Epirubicin—prostate cancer	0.00132	0.00133	CcSEcCtD
Emedastine—Rhinitis—Doxorubicin—prostate cancer	0.00132	0.00132	CcSEcCtD
Emedastine—Asthenia—Etoposide—prostate cancer	0.00129	0.0013	CcSEcCtD
Emedastine—Pain—Docetaxel—prostate cancer	0.00128	0.00129	CcSEcCtD
Emedastine—Pruritus—Etoposide—prostate cancer	0.00128	0.00128	CcSEcCtD
Emedastine—Nervous system disorder—Prednisone—prostate cancer	0.00127	0.00127	CcSEcCtD
Emedastine—Tachycardia—Prednisone—prostate cancer	0.00126	0.00127	CcSEcCtD
Emedastine—Skin disorder—Prednisone—prostate cancer	0.00126	0.00126	CcSEcCtD
Emedastine—Mental disorder—Epirubicin—prostate cancer	0.00125	0.00125	CcSEcCtD
Emedastine—Pain—Capecitabine—prostate cancer	0.00124	0.00125	CcSEcCtD
Emedastine—Eye disorder—Doxorubicin—prostate cancer	0.00123	0.00123	CcSEcCtD
Emedastine—Cardiac disorder—Doxorubicin—prostate cancer	0.00122	0.00123	CcSEcCtD
Emedastine—Dysgeusia—Epirubicin—prostate cancer	0.00121	0.00122	CcSEcCtD
Emedastine—Vision blurred—Epirubicin—prostate cancer	0.00117	0.00117	CcSEcCtD
Emedastine—Mental disorder—Doxorubicin—prostate cancer	0.00115	0.00116	CcSEcCtD
Emedastine—Rash—Etoposide—prostate cancer	0.00114	0.00114	CcSEcCtD
Emedastine—Dermatitis—Etoposide—prostate cancer	0.00114	0.00114	CcSEcCtD
Emedastine—Headache—Etoposide—prostate cancer	0.00113	0.00113	CcSEcCtD
Emedastine—Dysgeusia—Doxorubicin—prostate cancer	0.00112	0.00113	CcSEcCtD
Emedastine—Olanzapine—CYP3A4—prostate cancer	0.00112	0.389	CrCbGaD
Emedastine—Vision blurred—Doxorubicin—prostate cancer	0.00108	0.00108	CcSEcCtD
Emedastine—Asthenia—Docetaxel—prostate cancer	0.00108	0.00108	CcSEcCtD
Emedastine—Pruritus—Docetaxel—prostate cancer	0.00106	0.00106	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.00105	0.00105	CcSEcCtD
Emedastine—Discomfort—Epirubicin—prostate cancer	0.00104	0.00105	CcSEcCtD
Emedastine—Asthenia—Capecitabine—prostate cancer	0.00104	0.00104	CcSEcCtD
Emedastine—Pruritus—Capecitabine—prostate cancer	0.00103	0.00103	CcSEcCtD
Emedastine—Nervous system disorder—Epirubicin—prostate cancer	0.000992	0.000995	CcSEcCtD
Emedastine—Tachycardia—Epirubicin—prostate cancer	0.000987	0.00099	CcSEcCtD
Emedastine—Skin disorder—Epirubicin—prostate cancer	0.000982	0.000985	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.00097	0.000972	CcSEcCtD
Emedastine—Discomfort—Doxorubicin—prostate cancer	0.000965	0.000967	CcSEcCtD
Emedastine—Rash—Docetaxel—prostate cancer	0.000946	0.000948	CcSEcCtD
Emedastine—Dermatitis—Docetaxel—prostate cancer	0.000945	0.000947	CcSEcCtD
Emedastine—Headache—Docetaxel—prostate cancer	0.000939	0.000942	CcSEcCtD
Emedastine—Asthenia—Prednisone—prostate cancer	0.000928	0.000931	CcSEcCtD
Emedastine—Nervous system disorder—Doxorubicin—prostate cancer	0.000918	0.00092	CcSEcCtD
Emedastine—Rash—Capecitabine—prostate cancer	0.000915	0.000918	CcSEcCtD
Emedastine—Pruritus—Prednisone—prostate cancer	0.000915	0.000918	CcSEcCtD
Emedastine—Dermatitis—Capecitabine—prostate cancer	0.000915	0.000917	CcSEcCtD
Emedastine—Tachycardia—Doxorubicin—prostate cancer	0.000913	0.000916	CcSEcCtD
Emedastine—Headache—Capecitabine—prostate cancer	0.00091	0.000912	CcSEcCtD
Emedastine—Skin disorder—Doxorubicin—prostate cancer	0.000909	0.000912	CcSEcCtD
Emedastine—Pain—Epirubicin—prostate cancer	0.000865	0.000867	CcSEcCtD
Emedastine—Rash—Prednisone—prostate cancer	0.000815	0.000818	CcSEcCtD
Emedastine—Dermatitis—Prednisone—prostate cancer	0.000815	0.000817	CcSEcCtD
Emedastine—Headache—Prednisone—prostate cancer	0.00081	0.000813	CcSEcCtD
Emedastine—Pain—Doxorubicin—prostate cancer	0.0008	0.000803	CcSEcCtD
Emedastine—Asthenia—Epirubicin—prostate cancer	0.000726	0.000728	CcSEcCtD
Emedastine—Pruritus—Epirubicin—prostate cancer	0.000716	0.000718	CcSEcCtD
Emedastine—Asthenia—Doxorubicin—prostate cancer	0.000671	0.000673	CcSEcCtD
Emedastine—Pruritus—Doxorubicin—prostate cancer	0.000662	0.000664	CcSEcCtD
Emedastine—Rash—Epirubicin—prostate cancer	0.000638	0.00064	CcSEcCtD
Emedastine—Dermatitis—Epirubicin—prostate cancer	0.000637	0.000639	CcSEcCtD
Emedastine—Headache—Epirubicin—prostate cancer	0.000634	0.000635	CcSEcCtD
Emedastine—Rash—Doxorubicin—prostate cancer	0.00059	0.000592	CcSEcCtD
Emedastine—Dermatitis—Doxorubicin—prostate cancer	0.00059	0.000591	CcSEcCtD
Emedastine—Headache—Doxorubicin—prostate cancer	0.000586	0.000588	CcSEcCtD
